John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Saia
SAIA
$9.66B
| $10.6M | 0.04% |
+56,334
| New | +$11.3M |
|
477
CVR Energy
CVI
$3.97B
| $10.6M | 0.03% |
316,064
+168,754
| +115% | +$5.39M |
|
478
W.R. Berkley
WRB
$25.5B
| $10.6M | 0.03% |
232,023
-22,734
| -9% | -$1.03M |
|
479
Eastman Chemical
EMN
$8.47B
| $10.5M | 0.03% |
117,204
-376,132
| -76% | -$38.9M |
|
480
CareDx
CDNA
$2.51B
| $10.5M | 0.03% |
489,766
+196,402
| +67% | +$5.45M |
|
481
Customers Bancorp
CUBI
$2.69B
| $10.5M | 0.03% |
309,128
+242,130
| +361% | +$9.84M |
|
482
B&G Foods
BGS
$281M
| $10.4M | 0.03% |
436,261
+214,468
| +97% | +$5.33M |
|
483
Alkermes
ALKS
$8.11B
| $10.3M | 0.03% |
347,345
+113,235
| +48% | +$3.25M |
|
484
Live Oak Bancshares
LOB
$1.9B
| $10.3M | 0.03% |
305,207
+213,332
| +232% | +$8.82M |
|
|
ROIC
485
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $10.3M | 0.03% |
652,510
+274,848
| +73% | +$4.9M |
|
486
Bio-Rad Laboratories Class A
BIO
$10.2B
| $10.3M | 0.03% |
20,780
-52,057
| -71% | -$27.1M |
|
487
Dynatrace
DT
$14.2B
| $10.3M | 0.03% |
260,574
-568,081
| -69% | -$22.6M |
|
488
Ralph Lauren
RL
$22.2B
| $10.3M | 0.03% |
114,508
-68,220
| -37% | -$6.88M |
|
489
Gran Tierra Energy
GTE
$351M
| $10.2M | 0.03% |
890,499
+60,093
| +7% | +$957K |
|
490
AutoNation
AN
$6.6B
| $10.2M | 0.03% |
91,313
+31,339
| +52% | +$3.55M |
|
491
Hercules Capital
HTGC
$3.21B
| $10.2M | 0.03% |
755,999
-216,026
| -22% | -$3.37M |
|
492
JFrog
FROG
$11.4B
| $10.2M | 0.03% |
483,048
+14,883
| +3% | +$312K |
|
493
Monro
MNRO
$392M
| $10.1M | 0.03% |
236,393
+36,119
| +18% | +$1.61M |
|
494
Canadian Natural Resources
CNQ
$106B
| $10.1M | 0.03% |
+385,223
| New | +$11.7M |
|
495
Packaging Corp of America
PKG
$22.5B
| $10.1M | 0.03% |
73,517
+43,014
| +141% | +$6.65M |
|
496
PUT
Beyond Meat
BYND
$254M
| $10.1M | 0.03% |
14,053
+2,933
| +26% | +$2.81M |
|
497
Cal-Maine
CALM
$3.87B
| $10.1M | 0.03% |
204,227
+173,934
| +574% | +$8.82M |
|
|
PACW
498
DELISTED
PacWest Bancorp
PACW
| $10.1M | 0.03% |
+378,521
| New | +$12.2M |
|
499
Coeur Mining
CDE
$21.6B
| $10.1M | 0.03% |
3,318,266
-1,258,585
| -27% | -$4.94M |
|
500
DigitalBridge
DBRG
$2.95B
| $10.1M | 0.03% |
516,277
+18,970
| +4% | +$463K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.